ADGI

Adagio Therapeutics (ADGI)

Adagio Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ADGI

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/29	20 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/05/26	07 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/05/26	07 : 43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/05/26	07 : 43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/05/26	07 : 38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/05/26	05 : 23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/04/13	05 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/04/13	05 : 47	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/04/11	05 : 20	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/04/11	05 : 11	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/04/11	05 : 08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/04/01	05 : 38	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/03/29	05 : 55	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/03/24	05 : 31	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/03/24	05 : 13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/03/06	23 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/02/10	01 : 48	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ADGI	Adagio Therapeutics Inc
2023/01/09	21 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/12/19	21 : 00	GlobeNewswire Inc.	Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA Workshop	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/12/17	07 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/12/17	07 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/12/17	07 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/12/17	07 : 11	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/12/07	06 : 29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/12/07	06 : 01	GlobeNewswire Inc.	Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/11/30	07 : 17	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/11/17	21 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/11/11	06 : 32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/11/11	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADGI	Adagio Therapeutics Inc
2022/11/05	05 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADGI	Adagio Therapeutics Inc